BMJ cohort study links GLP-1 drugs such as semaglutide to lower substance use disorder risk and reduced addiction-related complications in adults with diabetes.

Research suggests the drugs have potential for prevention and harm reduction in substance use disorders, writes Ziyad Al-Aly People taking glucagon-like peptide-1 (GLP-1) receptor agonists often ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. One of the most prominent medical developments in recent years has ...

Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk ...

Researchers at the U of A Health Sciences Comprehensive Center for Pain & Addiction found a medication that reduced craving for cocaine without affecting desire for sugar. University of Arizona Health ...

HONOLULU (KHON2) — January is Substance Use Disorder Treatment Month, which is designed to raise awareness about those suffering with substance use. Addiction is a disease, and leaders at the Hawaiʻi ...